Medicare AdvantagePrior AuthMedium impact
MA11.068f, Sentinel Lymph Node Biopsy and Mapping
Independence Blue Cross·Oncology, General Surgery·Medical Policy
Effective date
Aug 25, 2025
We identified it
Jun 19, 2026
Summary
Policy MA11.068f establishes or updates medical necessity criteria for sentinel lymph node biopsy and mapping procedures effective August 25, 2025. This is a recent Medicare Advantage policy change that may affect prior authorization requirements and billing guidelines for these procedures. The billing team must review detailed coverage criteria to ensure compliant claim submission.
Action Required
By August 25, 2025: Billing team must obtain and review the complete policy text from the provided URL to identify specific affected CPT/HCPCS codes for sentinel lymph node biopsy and mapping. Update billing system with any new prior authorization requirements, medical necessity documentation needs, or coverage restrictions. Coordinate with providers to ensure encounter documentation aligns with updated medical necessity criteria. Flag all claims for these procedures submitted after the effective date for compliance verification until internal processes are confirmed.